Aptamer Group (LON:APTA) Shares Down 8.7% – Here’s Why

Aptamer Group plc (LON:APTAGet Free Report) shares fell 8.7% during mid-day trading on Tuesday . The company traded as low as GBX 0.50 and last traded at GBX 0.50. 71,147 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 4,775,547 shares. The stock had previously closed at GBX 0.55.

Aptamer Group Stock Performance

The firm has a market cap of £16.86 million, a price-to-earnings ratio of -4.44 and a beta of 0.90. The business has a fifty day moving average of GBX 0.56 and a two-hundred day moving average of GBX 0.74.

Aptamer Group Company Profile

(Get Free Report)

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.

Featured Stories

Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.